» Articles » PMID: 38792336

Serum Plasminogen Activator Inhibitor-1, α 1-Acid Glycoprotein, C-Reactive Protein, and Platelet Factor 4 Levels-Promising Molecules That Can Complete the "Puzzle" of the Biochemical Milieu in Severe Burns: Preliminary Results of a Cohort...

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 May 25
PMID 38792336
Authors
Affiliations
Soon will be listed here.
Abstract

: Burns represent a serious health problem, associated with multiple-organ failure, prolonged hospitalization, septic complications, and increased rate of mortality. The main aim of our study was to evaluate the levels of various circulating molecules in children with severe burns (more than 25% TBSA), in three different moments: 48 h, day 10, and day 21 post-burn. : This study included 32 children with burns produced by flame, hot liquid, and electric arc and 21 controls. Serum plasminogen activator inhibitor-1 (PAI-1), α 1-acid glycoprotein (AGP), C-reactive protein (CRP), and platelet factor 4 (PF4) were detected using the Multiplex technique. Several parameters, such as fibrinogen, leucocyte count, thrombocyte count, triiodothyronine, thyroxine, and thyroid-stimulating hormone were also determined for each patient during hospitalization. : Significant statistical differences were obtained for CRP, AGP, and PF4 compared to the control group, in different moments of measurements. Negative correlations between CRP, AGP, and PF4 serum levels and burned body surface, and also the hospitalization period, were observed. CRP levels increased in the first 10 days after burn trauma and then decreased after day 21. Serum PAI-1 levels were higher immediately after the burn and started decreasing only after day 10 post-burn. AGP had elevated levels 48 h after the burn, then decreased at 7-10 days afterwards, and once again increased levels after 21 days. PF4 serum levels increased after day 10 since the burning event. Serum CRP, AGP, PAI-1, and PF4 seem to be promising molecules in monitoring patients with a burn within the first 21 days.

Citing Articles

Strategies for Optimizing Acute Burn Wound Therapy: A Comprehensive Review.

Cretu A, Grosu-Bularda A, Bordeanu-Diaconescu E, Hodea F, Ratoiu V, Dumitru C Medicina (Kaunas). 2025; 61(1).

PMID: 39859110 PMC: 11766551. DOI: 10.3390/medicina61010128.


Our Experience and Clinical Findings in Perineal Burns: Implications for Patient Prognosis-A 3 Year Retrospective Study.

Iordache M, Bordeanu-Diaconescu E, Grosu-Bularda A, Andrei M, Frunza A, Grama S Medicina (Kaunas). 2025; 60(12.

PMID: 39768889 PMC: 11727808. DOI: 10.3390/medicina60122009.


Adipokines-A Cohort Prospective Study in Children with Severe Burns.

Badoiu S, Enescu D, Tatar R, Miricescu D, Stanescu-Spinu I, Greabu M Int J Mol Sci. 2024; 25(14).

PMID: 39062875 PMC: 11277113. DOI: 10.3390/ijms25147630.


Associations of Insulin Resistance and High-Sensitivity C-Reactive Protein with Metabolic Abnormalities in Korean Patients with Type 2 Diabetes Mellitus: A Preliminary Study.

Jeong Y, Lee B, Hur W, Lee M, Han S Metabolites. 2024; 14(7).

PMID: 39057694 PMC: 11279201. DOI: 10.3390/metabo14070371.

References
1.
Huang Z, Ung T . Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics. Curr Drug Metab. 2012; 14(2):226-38. View

2.
Sofianos C, Redant D, Muganza R, Moore R, Ferrar D . Thyroid Crisis in a Patient With Burn Injury. J Burn Care Res. 2017; 38(4):e776-e780. DOI: 10.1097/BCR.0000000000000499. View

3.
Huang Y, Lu G, Zhao H, Liu L, Jin J, Wu Y . Clinical features and mortality-related factors of extensive burns among young adults: the Kunshan disaster experience. Ann Transl Med. 2020; 8(17):1053. PMC: 7575965. DOI: 10.21037/atm-20-288. View

4.
Jian J, Pang Y, Yan H, Min Y, Achyut B, Hollander M . Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis. Oncotarget. 2016; 8(17):27725-27739. PMC: 5438604. DOI: 10.18632/oncotarget.9486. View

5.
Woznica-Niesobska E, Lesnik P, Janc J, Zalewska M, Lysenko L . The Role of Plasminogen Activator Inhibitor 1 in Predicting Sepsis-Associated Liver Dysfunction: An Observational Study. Int J Environ Res Public Health. 2023; 20(6). PMC: 10049524. DOI: 10.3390/ijerph20064846. View